Global and China Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Status and Forecast 2021-2027

SKU ID : QYR-19154107 | Publishing Date : 15-Sep-2021 | No. of pages : 106

Detailed TOC of Global and China Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Status and Forecast 2021-2027

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    1.3 Market by Application
        1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Lung
        1.3.3 Breast
        1.3.4 Colorectal
        1.3.5 Melanoma
        1.3.6 Prostate
        1.3.7 Head and Neck
        1.3.8 Ovarian
        1.3.9 Pancreatic
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2016-2027)
    2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Regions
        2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Share by Regions (2016-2021)
        2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2022-2027)
    2.3 Cancer Immunotherapy Drug Discovery Outsourcing Industry Dynamic
        2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Trends
        2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
        2.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
        2.3.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue
        3.1.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue (2016-2021)
        3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2016-2021)
    3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
    3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio
        3.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2020
    3.5 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
    3.6 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
    3.7 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Type
    4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2016-2021)
    4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2022-2027)

5 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Application
    5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2016-2021)
    5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027)
    6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
        6.2.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021)
        6.2.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027)
        6.2.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027)
    6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
        6.3.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021)
        6.3.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027)
        6.3.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027)
    6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
        6.4.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021)
        6.4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027)
    7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
        7.2.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021)
        7.2.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027)
        7.2.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027)
    7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
        7.3.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021)
        7.3.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027)
        7.3.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027)
    7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
        7.4.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021)
        7.4.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027)
    8.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
        8.2.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
        8.3.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region
        8.4.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027)
    9.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
        9.2.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021)
        9.2.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027)
        9.2.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027)
    9.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
        9.3.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021)
        9.3.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027)
        9.3.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027)
    9.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
        9.4.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021)
        9.4.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2016-2027)
    10.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
        10.2.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
        10.3.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
        10.4.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Aquila BioMedical
        11.1.1 Aquila BioMedical Company Details
        11.1.2 Aquila BioMedical Business Overview
        11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.1.5 Aquila BioMedical Recent Development
    11.2 BPS Bioscience, Inc.
        11.2.1 BPS Bioscience, Inc. Company Details
        11.2.2 BPS Bioscience, Inc. Business Overview
        11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.2.5 BPS Bioscience, Inc. Recent Development
    11.3 Celentyx Ltd
        11.3.1 Celentyx Ltd Company Details
        11.3.2 Celentyx Ltd Business Overview
        11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.3.5 Celentyx Ltd Recent Development
    11.4 Crown Bioscience, Inc.
        11.4.1 Crown Bioscience, Inc. Company Details
        11.4.2 Crown Bioscience, Inc. Business Overview
        11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.4.5 Crown Bioscience, Inc. Recent Development
    11.5 DiscoverX Corporation
        11.5.1 DiscoverX Corporation Company Details
        11.5.2 DiscoverX Corporation Business Overview
        11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.5.5 DiscoverX Corporation Recent Development
    11.6 Explicyte
        11.6.1 Explicyte Company Details
        11.6.2 Explicyte Business Overview
        11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.6.5 Explicyte Recent Development
    11.7 Genscript Biotech Corporation
        11.7.1 Genscript Biotech Corporation Company Details
        11.7.2 Genscript Biotech Corporation Business Overview
        11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.7.5 Genscript Biotech Corporation Recent Development
    11.8 HD Biosciences Co.
        11.8.1 HD Biosciences Co. Company Details
        11.8.2 HD Biosciences Co. Business Overview
        11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.8.5 HD Biosciences Co. Recent Development
    11.9 Horizon Discovery Group PLC
        11.9.1 Horizon Discovery Group PLC Company Details
        11.9.2 Horizon Discovery Group PLC Business Overview
        11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.9.5 Horizon Discovery Group PLC Recent Development
    11.10 ImmunXperts SA
        11.10.1 ImmunXperts SA Company Details
        11.10.2 ImmunXperts SA Business Overview
        11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.10.5 ImmunXperts SA Recent Development
    11.11 Molecular Imaging, Inc.
        11.11.1 Molecular Imaging, Inc. Company Details
        11.11.2 Molecular Imaging, Inc. Business Overview
        11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.11.5 Molecular Imaging, Inc. Recent Development
    11.12 Promega Corporation,Personalis, Inc.
        11.12.1 Promega Corporation,Personalis, Inc. Company Details
        11.12.2 Promega Corporation,Personalis, Inc. Business Overview
        11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.12.5 Promega Corporation,Personalis, Inc. Recent Development
    11.13 STC Biologics
        11.13.1 STC Biologics Company Details
        11.13.2 STC Biologics Business Overview
        11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction
        11.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
        11.13.5 STC Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global and China Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Status and Forecast 2021-2027

List of Tables
    Table 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2016-2021) & (US$ Million)
    Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2016-2021)
    Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2022-2027)
    Table 8. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends
    Table 9. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
    Table 10. Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
    Table 11. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
    Table 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2016-2021) & (US$ Million)
    Table 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players (2016-2021)
    Table 14. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2020)
    Table 15. Ranking of Global Top Cancer Immunotherapy Drug Discovery Outsourcing Companies by Revenue (US$ Million) in 2020
    Table 16. Global 5 Largest Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue (CR5 and HHI) & (2016-2021)
    Table 17. Key Players Headquarters and Area Served
    Table 18. Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
    Table 19. Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
    Table 20. Mergers & Acquisitions, Expansion Plans
    Table 21. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million)
    Table 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2016-2021)
    Table 23. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 24. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 25. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 26. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2016-2021)
    Table 27. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 28. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 29. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million)
    Table 30. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million)
    Table 31. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million)
    Table 32. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million)
    Table 33. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million)
    Table 34. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million)
    Table 35. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million)
    Table 36. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million)
    Table 37. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million)
    Table 38. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million)
    Table 39. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million)
    Table 40. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million)
    Table 41. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million)
    Table 42. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2016-2021) & (US$ Million)
    Table 46. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2022-2027) & (US$ Million)
    Table 47. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million)
    Table 48. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million)
    Table 50. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million)
    Table 52. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million)
    Table 53. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2016-2021) (US$ Million)
    Table 54. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2016-2021) & (US$ Million)
    Table 58. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2022-2027) & (US$ Million)
    Table 59. Aquila BioMedical Company Details
    Table 60. Aquila BioMedical Business Overview
    Table 61. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 62. Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 63. Aquila BioMedical Recent Development
    Table 64. BPS Bioscience, Inc. Company Details
    Table 65. BPS Bioscience, Inc. Business Overview
    Table 66. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 67. BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 68. BPS Bioscience, Inc. Recent Development
    Table 69. Celentyx Ltd Company Details
    Table 70. Celentyx Ltd Business Overview
    Table 71. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 72. Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 73. Celentyx Ltd Recent Development
    Table 74. Crown Bioscience, Inc. Company Details
    Table 75. Crown Bioscience, Inc. Business Overview
    Table 76. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 77. Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 78. Crown Bioscience, Inc. Recent Development
    Table 79. DiscoverX Corporation Company Details
    Table 80. DiscoverX Corporation Business Overview
    Table 81. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 82. DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 83. DiscoverX Corporation Recent Development
    Table 84. Explicyte Company Details
    Table 85. Explicyte Business Overview
    Table 86. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 87. Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 88. Explicyte Recent Development
    Table 89. Genscript Biotech Corporation Company Details
    Table 90. Genscript Biotech Corporation Business Overview
    Table 91. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 92. Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 93. Genscript Biotech Corporation Recent Development
    Table 94. HD Biosciences Co. Company Details
    Table 95. HD Biosciences Co. Business Overview
    Table 96. HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 97. HD Biosciences Co. Recent Development
    Table 98. Horizon Discovery Group PLC Company Details
    Table 99. Horizon Discovery Group PLC Business Overview
    Table 100. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 101. Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 102. Horizon Discovery Group PLC Recent Development
    Table 103. ImmunXperts SA Company Details
    Table 104. ImmunXperts SA Business Overview
    Table 105. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 106. ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 107. ImmunXperts SA Recent Development
    Table 108. Molecular Imaging, Inc. Company Details
    Table 109. Molecular Imaging, Inc. Business Overview
    Table 110. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 111. Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 112. Molecular Imaging, Inc. Recent Development
    Table 113. Promega Corporation,Personalis, Inc. Company Details
    Table 114. Promega Corporation,Personalis, Inc. Business Overview
    Table 115. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 116. Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 117. Promega Corporation,Personalis, Inc. Recent Development
    Table 118. STC Biologics Company Details
    Table 119. STC Biologics Business Overview
    Table 120. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product
    Table 121. STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021) & (US$ Million)
    Table 122. STC Biologics Recent Development
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type: 2020 VS 2027
    Figure 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2020 VS 2027
    Figure 5. Lung Case Studies
    Figure 6. Breast Case Studies
    Figure 7. Colorectal Case Studies
    Figure 8. Melanoma Case Studies
    Figure 9. Prostate Case Studies
    Figure 10. Head and Neck Case Studies
    Figure 11. Ovarian Case Studies
    Figure 12. Pancreatic Case Studies
    Figure 13. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered
    Figure 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions: 2020 VS 2027
    Figure 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2022-2027)
    Figure 18. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players in 2020
    Figure 19. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2020
    Figure 21. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2016-2021)
    Figure 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2022-2027)
    Figure 23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027)
    Figure 25. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027)
    Figure 26. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027)
    Figure 27. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027)
    Figure 31. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027)
    Figure 32. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027)
    Figure 33. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2016-2027)
    Figure 43. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027)
    Figure 51. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027)
    Figure 52. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027)
    Figure 53. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2016-2027)
    Figure 59. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Aquila BioMedical Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 63. BPS Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 64. Celentyx Ltd Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 65. Crown Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 66. DiscoverX Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 67. Explicyte Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 68. Genscript Biotech Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 69. HD Biosciences Co. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 70. Horizon Discovery Group PLC Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 71. ImmunXperts SA Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 72. Molecular Imaging, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 73. Promega Corporation,Personalis, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 74. STC Biologics Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed

Keyplayers in Global and China Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Status and Forecast 2021-2027

Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]